Also trades as: 2552.HK (HKSE) · $vol 1M
HUMDF OTC
Hua Medicine (Shanghai) Ltd.
1W: +0.0%
1M: -13.7%
3M: -13.7%
YTD: -28.5%
1Y: -28.5%
3Y: -34.8%
$0.29
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.5B
-3.7% ▼
5Y CAGR: +4.2%
Total Liabilities
$464M
-72.1% ▼
5Y CAGR: -0.1%
Shareholders Equity
$1.0B
+843.3% ▲
5Y CAGR: +6.6%
Cash & Investments
$1.1B
-4.1% ▼
5Y CAGR: +1.2%
Total Debt
$302M
+0.5% ▲
5Y CAGR: +30.2%
Net Debt
-$791M
+5.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $675M | $491M | $1.5B | $1.1B | $1.1B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $675M | $491M | $1.5B | $1.1B | $1.1B |
| Net Receivables | $0 | $13M | $979K | $39M | $81M |
| Inventory | $0 | $2M | $68M | $127M | $122M |
| Other Current Assets | $29M | $414M | $43M | $27M | $195K |
| Total Current Assets | $705M | $940M | $1.6B | $1.3B | $1.3B |
| Property, Plant & Equip. | $157M | $140M | $115M | $130M | $110M |
| Goodwill & Intangibles | $9M | $32M | $29M | $26M | $23M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $33M | $10M | $10M | $35M | $41M |
| Total Non-Current Assets | $199M | $181M | $153M | $191M | $173M |
| Total Assets | $904M | $1.1B | $1.7B | $1.5B | $1.5B |
| — Liabilities — | |||||
| Accounts Payable | $24M | $21M | $52M | $64M | $82M |
| Short-Term Debt | $0 | $34M | $17M | $98M | $49M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $38M | $74M | $122M | $98M | $25M |
| Total Current Liabilities | $107M | $188M | $252M | $330M | $210M |
| Long-Term Debt | $0 | $0 | $107M | $139M | $221M |
| Other Non-Current Liab. | $288M | $611M | $1.2B | $0 | $0 |
| Total Non-Current Liabilities | $346M | $654M | $1.4B | $1.3B | $253M |
| Total Liabilities | $453M | $842M | $1.6B | $1.7B | $464M |
| — Equity — | |||||
| Common Stock | $7M | $7M | $7M | $7M | $7M |
| Retained Earnings | -$5.7B | -$5.9B | -$6.1B | -$6.4B | $0 |
| Accumulated OCI | $230M | $251M | $275M | $286M | $0 |
| Total Stockholders Equity | $450M | $280M | $101M | -$135M | $1.0B |
| Total Liabilities & Equity | $904M | $1.1B | $1.7B | $1.5B | $1.5B |
| — Key Metrics — | |||||
| Total Debt | $72M | $98M | $168M | $300M | $302M |
| Net Debt | -$604M | -$393M | -$1.3B | -$840M | -$791M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |